UK markets closed

Adverum Biotechnologies, Inc. (ADVM)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
10.43+0.43 (+4.30%)
At close: 04:00PM EDT
10.25 -0.18 (-1.73%)
After hours: 05:42PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-156,209
-117,165
-154,536
-145,540
-117,507
Depreciation & amortisation
6,138
5,644
6,528
4,645
4,158
Stock-based compensation
19,236
17,569
20,079
25,194
20,391
Change in working capital
14,500
-8,317
15,849
4,062
12,729
Accounts payable
-1,568
-369
845
-1,612
1,585
Other working capital
-131,414
-91,710
-119,907
-122,954
-91,135
Other non-cash items
-1,419
13,028
2,623
-25
75
Net cash provided by operating activities
-115,431
-90,902
-108,091
-107,831
-79,291
Cash flows from investing activities
Investments in property, plant and equipment
-15,983
-808
-11,816
-15,123
-11,844
Purchases of investments
-161,021
-36,718
-104,363
-407,514
-570,386
Sales/maturities of investments
340,373
134,401
257,899
501,346
302,063
Net cash used for investing activities
163,369
96,875
141,720
78,709
-280,167
Cash flows from financing activities
Debt repayment
0
-
0
-240
-61
Common stock issued
0
-
0
1,685
344,302
Other financing activities
-420
-420
-
-
-2,043
Net cash used provided by (used for) financing activities
740
69
607
2,397
355,985
Net change in cash
48,678
6,042
34,236
-26,725
-3,473
Cash at beginning of period
38,255
70,934
36,698
63,423
66,896
Cash at end of period
86,933
76,976
70,934
36,698
63,423
Free cash flow
Operating cash flow
-115,431
-90,902
-108,091
-107,831
-79,291
Capital expenditure
-15,983
-808
-11,816
-15,123
-11,844
Free cash flow
-131,414
-91,710
-119,907
-122,954
-91,135